Lung cancer is a deadly disease that has taken the lives of countless individuals around the world. It is a type of cancer that originates in the lungs, either in the cells lining the airways or in the tissue of the bronchial tubes or lungs. These abnormal cells grow out of control, creating tumors that can interfere with the normal functioning of the lungs and the body.
Lung cancer is a particularly dangerous and deadly cancer due to a few factors. For one, it is often hard to detect in the early stages of its development as it can take years for a person to show any kind of symptoms or problems. Early detection is key in the successful treatment of any form of cancer, thus, the late discovery of lung cancer makes it all the more deadly.
Another reason why lung cancer is so dangerous is the fact that it often spreads to other parts of the body. This process, known as metastasis, can allow cancer cells to travel through the bloodstream and lymphatic system to reach other organs. This makes it exponentially more difficult to treat, as the cancer is no longer confined to one area.
Gefitinib, also known commercially as gefitero, is a small-molecule oral drug used in the treatment of certain types of cancer, namely non-small cell lung cancer (NSCLC). Gefitinib is a type of targeted therapy drug that works by blocking a certain enzyme involved in tumor growth. It may be used as a first-line or second-line treatment for certain types of NSCLC, depending on the individual’s circumstances.
In conclusion, lung cancer is a deadly and hazardous form of cancer. It is important for people to understand the risks associated with smoking, and to take steps to protect their health. With early detection and treatment, it is possible to beat the disease. However, it requires constant vigilance and a proactive attitude to ensure the cancer is caught in time.
Also, read- Pediamate